Clinical ischemia-reperfusion injury: Driven by reductive rather than oxidative stress? A narrative review
- 1Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, the Netherlands.
- 2Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
- 3Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, the Netherlands; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
- 4Department of Clinical Chemistry & Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
- 0Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, the Netherlands.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Ischemia-reperfusion (IR) injury in kidneys is driven by metabolic dysfunction, not traditional factors. This study reveals a metabolic signature of IR injury, suggesting reductive stress as a key driver.
Area Of Science
- Nephrology
- Transplantation Biology
- Metabolic Medicine
Background
- Ischemia-reperfusion (IR) injury is a significant cause of organ dysfunction after transient ischemia.
- Preclinical therapies for IR injury often fail in clinical translation, highlighting a gap in understanding.
- Kidney donation and transplantation serve as a relevant clinical model for studying IR injury.
Purpose Of The Study
- To systematically investigate the mechanisms underlying clinical ischemia-reperfusion injury.
- To identify the key molecular events driving IR injury in a clinical setting.
- To explore potential therapeutic strategies targeting the identified mechanisms.
Main Methods
- Utilized kidney donation and transplantation as a clinical model for IR injury.
- Performed a systematic investigation into the molecular mechanisms of IR injury.
- Analyzed metabolic signatures and biochemical pathways associated with IR injury.
Main Results
- Identified a distinct metabolic signature for renal IR injury, challenging traditional culprits like reactive oxygen species, complement activation, or inflammation.
- Observed a post-reperfusion metabolic paralysis characterized by high-energy phosphate depletion and tricarboxylic acid cycle defects.
- Revealed compensatory activation of catabolic routes in response to metabolic dysfunction.
- Concluded that clinical IR injury is primarily driven by reductive stress.
Conclusions
- Clinical IR injury is characterized by a metabolic signature, not solely by inflammation or oxidative stress.
- Reductive stress emerges as a critical factor driving IR injury in the clinical context.
- Understanding these metabolic derangements and reductive stress is crucial for developing effective clinical therapies to restore redox balance.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

